SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,818 | +5.8% | 15 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,718 | -16.9% | 15 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,067 | +6.3% | 15 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,944 | +17.2% | 15 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,658 | +47.5% | 15 | 0.0% | 0.00% | – |
| Q2 2022 | $1,124 | -4.1% | 15 | 0.0% | 0.00% | – |
| Q1 2022 | $1,172 | -13.2% | 15 | 0.0% | 0.00% | – |
| Q4 2021 | $1,351 | -18.9% | 15 | -16.7% | 0.00% | -100.0% |
| Q3 2021 | $1,665 | +33.8% | 18 | +12.5% | 0.00% | – |
| Q2 2021 | $1,244 | +864.3% | 16 | +1500.0% | 0.00% | – |
| Q4 2019 | $129 | -95.2% | 1 | -97.2% | 0.00% | -100.0% |
| Q3 2019 | $2,712 | -50.4% | 36 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $5,470 | +27.5% | 36 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,291 | -70.0% | 36 | -72.5% | 0.00% | -66.7% |
| Q4 2018 | $14,296 | -32.4% | 131 | 0.0% | 0.01% | -35.7% |
| Q3 2018 | $21,158 | +22.2% | 131 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $17,316 | – | 131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |